Search

Search results

Current filters: HIV drugs, HIV, Treatment

148 search results

CDC recommends use of raltegravir (Isentress) for PEP

From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage

Biktarvy in women with HIV

From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage

Switching from Triumeq to Biktarvy

From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage

Switching to Biktarvy from a protease inhibitor–based regimen

From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage

Biktarvy becomes a treatment option in Canada

From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage

Agencies issue caution about use of dolutegravir by pregnant HIV-positive women

2018, CATIE
Research summary - Webpage

Dutch study ties HIV to erection problems in middle-aged men

2018, CATIE
Research summary - Webpage

Winnipeg doctors use dolutegravir and darunavir for simplifying treatment

2018, CATIE
Research summary - Webpage

Preliminary results of dolutegravir + 3TC for initial therapy of HIV

From TreatmentUpdate 224
2018, CATIE
Research summary - Webpage

Dolutegravir + 3TC as maintenance therapy—a pilot study

From TreatmentUpdate 224
2018, CATIE
Research summary - Webpage